Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Net Receivables history
Currency unavailable · from the balance sheet
No Net Receivables data reported for this period type.
Net Receivables vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $24.43M USD | +190.5% | +394.4% | 1.3% | |
| Jun 2026 | $24M USD | — | — | 3.4% | |
| Mar 2026 | $15M USD | — | — | 5.1% | |
| Mar 2026 | $10.63M USD | — | — | 7.9% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | +190.5% | +394.4% | 3.4% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.